---
title: "VCANBIO's subsidiary VUM02 injection has been approved for clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256535376.md"
description: "VCANBIO's wholly-owned subsidiary Wuhan Optics Valley VCANBIO Pharmaceutical Co., Ltd. received approval from the National Medical Products Administration on September 9, 2025, to conduct clinical trials for VUM02 injection. This injection is a cryopreserved cell preparation independently developed by the company, primarily used for the treatment of severe/critical pneumonia"
datetime: "2025-09-09T10:21:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256535376.md)
  - [en](https://longbridge.com/en/news/256535376.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256535376.md)
generator: "portal-rs"
---

# VCANBIO's subsidiary VUM02 injection has been approved for clinical trials

According to the Zhitong Finance APP, VCANBIO (600645.SH) announced that its wholly-owned subsidiary Wuhan Optics Valley VCANBIO Pharmaceutical Co., Ltd. received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration on September 9, 2025, for the use of VUM02 injection in the treatment of severe/critical pneumonia.

VUM02 injection (human umbilical cord-derived mesenchymal stem cell injection) is a cryopreserved cell preparation independently developed by our company. It is a new drug prepared from selected healthy newborn umbilical cord tissue through in vitro separation, expansion, harvesting, and cryopreservation, with the clinical intended indication for the treatment of severe/critical pneumonia

### Related Stocks

- [600645.CN](https://longbridge.com/en/quote/600645.CN.md)

## Related News & Research

- [10:03 ETDarkfin Labs, Founded by a Stem Cell Biologist, Brings Longevity Science to Ulta Beauty](https://longbridge.com/en/news/297798822.md)
- [Kalshi issues first lifetime ban for Republican politician over insider bets](https://longbridge.com/en/news/297684078.md)
- [California Moves to Shut Down Private Equity Takeovers of Law Firms](https://longbridge.com/en/news/297560908.md)
- [11:16 ET/C O R R E C T I O N -- Allies of Skin/](https://longbridge.com/en/news/297805717.md)
- [Zhongzi International seeks HKEX trading resumption from Sept. 1 after filing annual results](https://longbridge.com/en/news/297524727.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**